US Patent 7745461 Method of treating dry eye disorders
Patent 7745461 was granted and assigned to Alcon on June, 2010 by the United States Patent and Trademark Office.
All edits
Edits on 31 Oct, 2023
Golden AI
Edits made to:
Article (+94 characters)
Article
Patent abstract
The topical use of EgLN-3 inhibitors is disclosed for the treatment of dry eye.
Edits on 18 Sep, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Inventor Names
Peter G. Klimko0
Edits on 25 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07745461 Method of treating dry eye disorders US Patent 7745461 Method of treating dry eye disorders
Infobox
Patent Number
077454610
Patent Number
77454610
Edits on 24 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 25 Sep, 2022
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
077454610
Date of Patent
June 29, 2010
0Patent Application Number
116786550
Date Filed
February 26, 2007
0Official Website
Patent Primary Examiner
Edits on 3 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 4 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 07745461 Method of treating dry eye disorders
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
07745461
Date of patent
June 29, 2010
Patent application number
11678655
Date Filed
February 26, 2007
Patent primary examiner
Find more entities like US Patent 7745461 Method of treating dry eye disorders
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
